BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 11
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4323)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.
Item 
Count 
PDF71
WORD15
HTML2420
Figures (1-1)287
Tables (1-3)235
 Sum=3028
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse175
Download471
 Sum=646
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse131
Download407
 Sum=538
Nov 15, 2023 (publication date) through Feb 17, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Dharmapuri S, Özbek U, Jethra H, Jun T, Marron TU, Saeed A, Huang YH, Muzaffar M, Pinter M, Balcar L, Fulgenzi C, Amara S, Weinmann A, Personeni N, Scheiner B, Pressiani T, Navaid M, Bengsch B, Paul S, Khan U, Bettinger D, Nishida N, Mohamed YI, Vogel A, Gampa A, Korolewicz J, Cammarota A, Kaseb A, Galle PR, Pillai A, Wang YH, Cortellini A, Kudo M, D’Alessio A, Rimassa L, Pinato DJ, Ang C. Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(11): 1900-1912 [PMID: PMC10701235 DOI: 10.4251/wjgo.v15.i11.1900]
URL: https://www.wjgnet.com/1007-9327/full/v15/i11/1900.htm
Number Citing Articles
1
Ken Horisaki, Shusuke Yoshikawa, Shoichiro Mori, Wataru Omata, Arata Tsutsumida, Yoshio Kiyohara. Prognostic value of the CONUT score with immune checkpoint inhibitors as first‐line therapy for metastatic malignant melanoma. The Journal of Dermatology 2025;  doi: 10.1111/1346-8138.17613
2
Qian Wang, Tingting Wu, Ru Zhao, Yuanqin Li, Xuetao Chen, Shanmei Shen, Xiaowen Zhang. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy. Endocrine Practice 2024; 30(10): 943 doi: 10.1016/j.eprac.2024.07.006
3
Yunyi Du, Ying Zhang, Wenqi Zhao, Yuexiang Zhang, Fei Su, Xiaoling Zhang, Weiling Li, Wenqing Hu, Yongai Li, Jun Zhao. Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy. Human Vaccines & Immunotherapeutics 2024; 20(1) doi: 10.1080/21645515.2024.2398309
4
Ryo Morikawa, Kentaro Nitta, Shuntaro Yasuda, Yoshihito Kano, Rika Noji, Satoru Aoyama, Shingo Sato, Sadakatsu Ikeda, Ryuichi Okamoto, Masashi Nagata, Takehiko Mori, Mitsukuni Suenaga. Identification of risk factors for gastrointestinal immune–related adverse events associated with immune check point inhibitors. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2443955
5
Xinyu Zhang, Bei Zhang, Danfei Li, Yunchao Yang, Sen Lin, Ruiqi Zhao, Yijia Li, Lisheng Peng. Peripheral blood cell counts as predictors of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1528084
6
Qiu-Yu Jiang, Ru-Yi Xue. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: Markers predicting immune-checkpoint inhibitor efficacy and immune-related adverse events. World Journal of Gastrointestinal Oncology 2024; 16(3): 577-582 doi: 10.4251/wjgo.v16.i3.577
7
Ben Ponvilawan, Abdul Wali Khan, Janakiraman Subramanian, Dhruv Bansal. Non-Invasive Predictive Biomarkers for Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors. Cancers 2024; 16(6): 1225 doi: 10.3390/cancers16061225
8
Zhenli Li, Tiezhu Yao, Guang Liu, Zhengkun Guan, Jing Liu, Ling Guo, Jingtao Ma. Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis. Journal of Cancer Research and Clinical Oncology 2024; 150(5) doi: 10.1007/s00432-024-05801-7
9
Qiang Zhao, Liang Wang, Xun Yang, Jifeng Feng, Qixun Chen. Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1418286
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345